AZ asthma biologic cuts exacerbations, improves symptoms
The Lancet has published data from two trials of AstraZeneca’s biologic benralizumab showing that the drug significantly reduced exacerbations and improved lung function and symptoms in patients with severe eosinophilic asthma.
Read More
